Skip to main content

Security report for phyteneo.cz

ENEO Pharmaceuticals s. r. o. · Healthcare · Czech Republic

Medium risk. 9 critical or high findings in GDPR outside view, Security headers and 2 other checks.

Security score

63/100

Risk levelMedium

0–100, higher is better. How it is calculated

ENEO Pharmaceuticals s. r. o. is a Czech-based pharmaceutical company specializing in innovative medicinal products and medical devices. With over 15 years of experience, the company focuses on developing unique solutions that have earned trust and awards in their field. Their product portfolio includes antiseptic solutions, skin treatments, and ear drops, targeting patients and healthcare professionals. The company also engages in research and development projects and supports business partners through a dedicated portal. Technically, the website employs modern web technologies including jQuery, Foundation framework, and integrates Google Analytics 4 and Meta Pixel for analytics and marketing. The site is mobile-optimized with a cookie consent mechanism compliant with GDPR. However, explicit security headers are missing, and WHOIS data for the domain is unavailable, which impacts domain trust. Security posture is generally good with HTTPS enforced and secure form validation, but the absence of a published security policy or vulnerability disclosure reduces transparency. Privacy compliance is strong with clear cookie consent and a comprehensive privacy policy. Contact information is readily available, including emails, phone, and physical address. Overall, the website presents a professional and trustworthy front for the business, but domain registration opacity and minor security header omissions suggest areas for improvement to enhance trust and security posture.

Scanned

NIS2 and GDPR posture

GDPR outside view
25/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

9 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching phyteneo.cz

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
77
Security headers
15
Email security
77
DNS health
85
Network security
100
GDPR outside view
25
Average
63

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

ENEO operates in the healthcare sector with a focus on pharmaceutical manufacturing and medical device development. Their market position is that of a specialized, innovative small company with a strong emphasis on product quality and research. The business model includes direct product sales and partnerships via a dedicated portal. Revenue streams likely derive from product sales and collaborations. The target customers are patients, healthcare providers, and business partners. The company demonstrates growth through ongoing R&D projects and maintains partnerships with Czech institutions. The website content and branding are consistent, supporting a credible market presence.

Security posture

The website demonstrates a moderate to good security maturity level. HTTPS is enforced, and cookie consent is implemented with opt-in mechanisms. Form inputs have client-side validation. However, the lack of explicit security headers such as Content Security Policy, HSTS, and X-Frame-Options is a gap. No public vulnerability disclosure or security.txt file is present, limiting transparency. Incident response contact is provided for pharmacovigilance but no general security contact is listed. GDPR compliance is well addressed. Overall, the security posture is adequate for the business type but could be improved with additional headers and published policies.

Recommendations

  1. Implement and publish a security policy and incident response page to improve transparency.
  2. Add standard security headers (CSP, HSTS, X-Frame-Options) to enhance protection against common web attacks.
  3. Publish a vulnerability disclosure policy or security.txt file to encourage responsible reporting.
  4. Regularly audit and update third-party scripts to mitigate risks from external dependencies.
  5. Enhance accessibility features to improve compliance and user experience for all users.

Contact details published on the site

Addresses
Legal name
ENEO Pharmaceuticals s. r. o.
VAT number
CZ25929763
Registration number
25929763
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
ENEO Pharmaceuticals s. r. o.
Description
ENEO Pharmaceuticals produces unique pharmaceutical products with a focus on innovation and patient solutions. They have a history of over 15 years, manufacturing medicinal products and medical devices, and have helped cure millions of warts and processed large quantities of herbs.
Key services
Pharmaceutical product manufacturing, Medical device development, Research and development projects, Partner portal for business customers
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Google Analytics 4, Facebook Pixel, Orejime cookie consent, Foundation framework
Frameworks
Foundation
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent with opt-in mechanism
  • No exposed sensitive data in HTML
  • Form validation on contact form

Analytics and tracking

Services
Google Analytics 4, Meta Pixel
Tracking level
extensive
Privacy practices
good

Advertising

Ad networks
Facebook Ads, Google Ads
Tracking pixels
Meta Pixel, Google Analytics 4
Marketing tools
Orejime cookie consent
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and multiple language options.
  2. Strong focus on pharmaceutical products and medical devices.
  3. Comprehensive cookie consent and privacy policy in place.
  4. Contact form with validation and multiple contact channels provided.
  5. No WHOIS data available, which is unusual and reduces domain trust.
  6. No explicit security headers detected in HTML source.
  7. Use of modern analytics and marketing tools with opt-in consent.
  8. No terms of service or explicit security policy pages found.
  9. No vulnerability disclosure or security.txt file present.
Technical notes

Notes

The website uses a modern tech stack including jQuery and the Foundation framework, providing responsive design and good user experience. Analytics and marketing tools are integrated with user consent. Performance is moderate with no major issues detected. The site lacks a CMS indication and hosting provider details are not evident. Technical debt appears low but the absence of security headers and WHOIS data suggests areas for technical improvement. The contact form uses client-side validation but could benefit from server-side validation and CAPTCHA to prevent abuse.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with phyteneo.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review phyteneo.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.